Target intelligence / Profile preview

TCEAL3 antisense RNA 1 (TCEAL3-AS1)

Target: TCEAL3-AS1
Molecular classification: Long non-coding RNA (lncRNA)

Overview

TCEAL3 antisense RNA 1 (TCEAL3-AS1) is a long non-coding RNA (lncRNA) gene associated with the TCEAL3 locus, transcribed in an antisense orientation relative to the TCEAL3 protein-coding gene[3]. It belongs to the lncRNA class and does not encode a protein. There is currently no evidence that TCEAL3-AS1 acts as a therapeutic target, nor are there known biological functions, disease roles, drug interactions, or safety concerns described for this RNA[3]. The gene is listed in public genomic databases with the aliases above, but its specific physiological and pathological roles remain undefined.

Other names: TCEAL3 Antisense RNA 1lnc-TCEAL3-1ENSG00000224031NCBI Gene: 100874119

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on TCEAL3 antisense RNA 1 (TCEAL3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCEAL3 antisense RNA 1 (TCEAL3-AS1).

Explore the full profile